highdose βcarotene supplementation in highrisk persons has been linked to increased lung cancer risk in clinical trials whether effects are similar in the general population is unclearthe authors examined associations of supplemental βcarotene retinol vitamin a lutein and lycopene with lung cancer risk among participants aged 5076 years in the vitamins and lifestyle vital cohort study in washington statein 20002002 eligible persons n  77126 completed a 24page baseline questionnaire including detailed questions about supplement use duration frequency dose during the previous 10 years from multivitamins and individual supplementsmixturesincident lung cancers n  521 through december 2005 were identified by linkage to the surveillance epidemiology and end results cancer registrylonger duration of use of individual βcarotene retinol and lutein supplements but not total 10year average dose was associated with statistically significantly elevated risk of total lung cancer and histologic cell types for example hazard ratio  202 95 confidence interval 128 317 for individual supplemental lutein with total lung cancer and hazard ratio  322 95 confidence interval 129 807 for individual βcarotene with smallcell lung cancer for 4 years versus no usethere was little evidence for effect modification by gender or smoking statuslongterm use of individual βcarotene retinol and lutein supplements should not be recommended for lung cancer prevention particularly among smokers